The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy.
about
Dynamic dissociating homo-oligomers and the control of protein functionConformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 Å resolutionSolution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain SwappingA designed chimeric cyanovirin-N homolog lectin: Structure and molecular basis of sucrose bindingAnti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by DimerizationStructure-Function Analysis of a CVNH-LysM Lectin Expressed during Plant Infection by the Rice Blast Fungus Magnaporthe oryzaeStructural Insights into the Anti-HIV Activity of the Oscillatoria agardhii Agglutinin Homolog Lectin FamilyDesigned oligomers of cyanovirin-N show enhanced HIV neutralizationBurkholderia oklahomensisagglutinin is a canonical two-domain OAA-family lectin: structures, carbohydrate binding and anti-HIV activityStructural basis for receptor recognition and pore formation of a zebrafish aerolysin-like proteinProgress towards the treatment of Ebola haemorrhagic fever.Antiviral lectins as potential HIV microbicidesExtraction and purification of a lectin from red kidney bean and preliminary immune function studies of the lectin and four Chinese herbal polysaccharidesLonger simulations sample larger subspaces of conformations while maintaining robust mechanisms of motionThe evolving field of biodefence: therapeutic developments and diagnostics.Effect of Nigella sativa alcoholic extract and oil, as well as Phaseolus vulgaris (kidney bean) lectin on the ultrastructure of Trichomonas vaginalis trophozoitesDirect measurement of glyconanoparticles and lectin interactions by isothermal titration calorimetryEnvelope-receptor interactions in Nipah virus pathobiology.Efficient synthesis of Man2, Man3, and Man5 oligosaccharides, using mannosyl iodide donors.Sensing lectin-glycan interactions using lectin super-microarrays and glycans labeled with dye-doped silica nanoparticlesThe griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.Purification and characterization of a lectin from Phaseolus vulgaris cv. (Anasazi beans).Fluorinated carbohydrates as lectin ligands: dissecting glycan-cyanovirin interactions by using 19F NMR spectroscopy.Multivalent glyconanoparticles with enhanced affinity to the anti-viral lectin Cyanovirin-N.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Inhibition of HIV-1 entry: multiple keys to close the door.Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches.Structure and Glycan Binding of a New Cyanovirin-N Homolog.Mushroom lectins: specificity, structure and bioactivity relevant to human disease.Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans.Network visualization of conformational sampling during molecular dynamics simulation.Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cellsNMR study of hydroxy protons of di- and trimannosides, substructures of Man-9.A versatile strategy for the synthesis of N-linked glycoamino acids from glycals.Concurrent purification of two defense proteins from French bean seeds: a defensin-like antifungal peptide and a hemagglutinin.A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.
P2860
Q24619847-37E84183-345E-4718-A97A-59E7E51680D3Q27650458-D78BBABA-E2F4-4DAF-AC6B-20E2ECE0F14EQ27651425-423C0676-A4BC-47BC-9036-6966FDF3F3E3Q27656745-C7506265-2252-446C-B073-3D4C114ABCCBQ27659715-1F01BB24-F895-4132-B250-58B9D22126B6Q27667816-07789D5E-31FF-4226-A8E1-1736B837090CQ27671174-6127F509-5796-4958-A945-4E401380B026Q27671182-DA60C311-FCA1-4C29-A9B6-0F4E23F8E58EQ27676767-ADEE206A-500F-4B7B-8CA9-4F3F3CED58D5Q27703260-E2D2B678-DB99-4E86-A9C5-8B7D87C36CADQ30230272-30F95445-4DB3-48E4-A42D-EA5E04F7B22EQ34112159-3E28349B-03E1-45D3-9D40-E2EA7010BF43Q34189082-99F9DE30-DAEA-40E6-92E4-FEB48FF07A78Q35791084-86F0AD9D-69B0-41A7-9EF6-B119567AD11EQ36085668-D75828C9-3026-4468-BD52-8A0F9FAF46D4Q36126000-477DD8DD-8E3F-4779-8B08-61220F3F428AQ36478846-E817758B-B1FE-4C0A-A2C1-9868DDA182E6Q36807254-67AED859-2E6C-45C0-874F-00AD7D44F1ABQ36844082-D0338615-D895-4045-8A66-A5BBFF8001DEQ36868007-4661841F-8A56-4882-B4E2-9D19D883A7BFQ37036454-E2E0786F-6E22-4B77-92EE-53EE2B3E24AAQ37140974-DD5AC1C9-7C57-4875-8069-944463B04478Q37230451-EF63B6FE-515E-4EB7-A969-64E3EE9B39F6Q37239583-193151DD-2781-405E-8131-04FB0FE03019Q37767654-891DDF10-244C-4CD3-9D88-3ED1180B25D8Q37789226-88AE5C58-96BD-4838-9887-F37D9B86B165Q37828538-3B88D235-F4C5-437E-A124-2E41C1D137DCQ38141060-FC9074F8-930F-4D56-879A-3197442CAB0DQ38291748-B435B675-5E4C-4D86-9E30-8CFE48C3FDB6Q38412878-D60B374E-6AAD-4BEC-832D-117EC00C2FA9Q40261250-F90F6AD8-6A1C-495C-A831-3F363CA9FE56Q41875115-BC65B5BF-FD2A-4A24-A854-A397CEE55E66Q41888076-EC80BF3F-0009-4615-9AA5-D97B2813DD55Q46877587-4C5B3E91-9CE4-4112-B004-69246A0D3201Q46899336-06BA79F9-B4D7-4CCB-940A-91B01FC07A32Q50463147-4D1B2548-6548-4FE7-BBC8-CE5B5D6FE47EQ51799133-7D097B26-6147-4AE8-BEC4-5E3AF0E3314AQ51805853-E1DED7FE-8423-43FB-B96D-E2BBF1944043
P2860
The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The highly specific carbohydra ...... and possibilities for therapy.
@ast
The highly specific carbohydra ...... and possibilities for therapy.
@en
The highly specific carbohydra ...... and possibilities for therapy.
@nl
type
label
The highly specific carbohydra ...... and possibilities for therapy.
@ast
The highly specific carbohydra ...... and possibilities for therapy.
@en
The highly specific carbohydra ...... and possibilities for therapy.
@nl
prefLabel
The highly specific carbohydra ...... and possibilities for therapy.
@ast
The highly specific carbohydra ...... and possibilities for therapy.
@en
The highly specific carbohydra ...... and possibilities for therapy.
@nl
P356
P1476
The highly specific carbohydra ...... and possibilities for therapy.
@en
P2093
Laura G Barrientos
P356
10.2174/1389557053402783
P577
2005-01-01T00:00:00Z